,trastuzumab deruxtecan
astrazeneca,daiichi sankyo
['mbc', 'bcsm', 'breast', 'destiny-breast04']
highly anticipated destiny-breast04 results! wow, standing ovation from the audience, just amazing results for our patients. new standard of care in her-2 low mbc. #bcsm #asco22 
Breast Medical Oncologist @UTHealthSAMDA. Former Heme/Onc Fellow @MontefioreNYC. Former IM resident @UTHimres. Alum @UNC. Dog Mom #breastcancer #BCSM